Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 04/2017
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

SPOT ON
Amount of refund according to the AMNOG (Pharmaceutical Market Restructuring Act) Higher Social Court questions calculation and cost effectiveness
FOURIER study with evolocumab (REPATHA) 2 million per prevented event

THERAPY FROM A CRITICAL VIEWPOINT
Rivaroxaban for extended prophylaxis after thromboembolism?
Are antibiotics unnecessary in uncomplicated diverticulitis?
Bicalutamide (CASODEX 150 mg, generics) in PSA-recurrent prostate cancer after prostatectomy

CURRENT ADR NETWORK REPORT
Anisocoria with escitalopram (CIPRALEX, generics)  free article 

IN BRIEF
Dabigatran (PRADAXA) versus warfarin (COUMADIN) for ablation in atrial fibrillation
PRAC recommends suspension of marketing authorisations of four MRI contrast agents
Finally Servier ceases distribution of strontium ranelate (PROTELOS)
FASTJECT lots recalled

e a-t ON THE INTERNET
France: 3rd and 4th generation contraceptives less and less prescribed
© 2020 arznei-telegramm